Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound

  1. López-Huertas, M.R.
  2. Gutiérrez, C.
  3. Madrid-Elena, N.
  4. Hernández-Novoa, B.
  5. Olalla-Sierra, J.
  6. Plana, M.
  7. Delgado, R.
  8. Rubio, R.
  9. Muñoz-Fernández, M.Á.
  10. Moreno, S.
Revue:
Scientific Reports

ISSN: 2045-2322

Année de publication: 2020

Volumen: 10

Número: 1

Type: Article

DOI: 10.1038/S41598-020-79002-W GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus